Other
Terazosin Hydrochloride Capsule, USP
Terazosin Hydrochloride Capsule
FDA Label NDC 24689-003
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Apnar Pharma Lp for the product Terazosin Hydrochloride (NDC 24689-003). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Package Label.Principal Display Panel
NDC 24689-001-01
Rx only
Terazosin
Capsules, USP
1 mg
Pharmacist: Please dispense with patient information sheet.
100 capsules
1 mg-100s (3c52c76c D0ca 46e7 Bd3c 6192b20c995d 01)
NDC 24689-002-01
Rx only
Terazosin
Capsules, USP
2 mg
Pharmacist: Please dispense with patient information sheet.
100 capsules
2 mg (100s)
NDC 24689-003-01
Rx only
Terazosin
Capsules, USP
5 mg
Pharmacist: Please dispense with patient information sheet.
100 capsules
5 mg (100s)
NDC 24689-004-01
Rx only
Terazosin
Capsules, USP
10 mg
Pharmacist: Please dispense with patient information sheet.
100 capsules
10 mg (100s)
* Please review the disclaimer below.
